Announcements Trials

Browse Landscape

Phase

Phase NA 89 Phase 1 15 Phase 2 14 Phase 1/2 6 Phase EARLY_PHASE1 4 Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pathologic Complete Response 1

Interventions

Cisplatin 725 Carboplatin 607 Paclitaxel 578 Cyclophosphamide 516 Radiotherapy 511 Docetaxel 475 Fluorouracil 453 Gemcitabine 437 Doxorubicin 383 Capecitabine 361 Dexamethasone 327 Oxaliplatin 288 pembrolizumab 283 Leucovorin 282 Bevacizumab 275 Etoposide 271 Vincristine 270 Rituximab 246 Prednisone 222 Pemetrexed 217 Cytarabine 205 Drug Therapy 194 Trastuzumab 175 Irinotecan 172 Methotrexate 171 Lenalidomide 137 Nivolumab 135 Filgrastim 135 Epirubicin 129 Tamoxifen 127

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Magnetic Resonance Imaging × Clear all

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡